Literature DB >> 14530510

Negative regulation of interleukin-12 production by a rapamycin-sensitive signaling pathway: a brief communication.

Suwannee Uthaisangsook1, Noorbibi K Day, Remi Hitchcock, Aaron Lerner, Michelle James-Yarish, Robert A Good, Soichi Haraguchi.   

Abstract

Interleukin-12 (IL-12), an important cytokine in host defense against microbial pathogens, regulates natural killer and T-cell function(s) including the induction of gamma-interferon production. The major cellular sources of IL-12 are monocytes/macrophages. Bacteria, bacterial products, and intracellular parasites are the most efficient inducers of IL-12 production. In the present study we show that a signal transduction pathway sensitive to rapamycin may have an important role in the regulation/suppression of Staphylococcus aureus-induced IL-12 production in vitro. Human peripheral blood mononuclear cells, monocytes, or a human monocytic cell line THP-1 were stimulated with S. aureus Cowan strain 1 (SAC) in the presence or absence of rapamycin and investigated for production of IL-12 protein by enzyme-linked immunosorbent assay and IL-12 p40 mRNA accumulation by RNase protection assay or real-time quantitative polymerase chain reaction. The results show that rapamycin significantly enhances SAC-induced IL-12 p70 protein production and IL-12 p40 mRNA accumulation. Further the results demonstrate that wortmannin enhances SAC-induced IL-12 p40 mRNA accumulation, whereas Ly294002 does not. These data indicate that a rapamycin-sensitive signaling pathway may act as a negative feedback cascade in the regulatory mechanisms of IL-12 production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530510     DOI: 10.1177/153537020322800906

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  3 in total

Review 1.  A potent immunosuppressive retroviral peptide: cytokine patterns and signaling pathways.

Authors:  Soichi Haraguchi; Robert A Good; Noorbibi K Day-Good
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 2.  Immunostimulatory activity of lifespan-extending agents.

Authors:  José Manuel Bravo-San Pedro; Laura Senovilla
Journal:  Aging (Albany NY)       Date:  2013-11       Impact factor: 5.682

3.  Low dose rapamycin exacerbates autoimmune experimental uveitis.

Authors:  Zili Zhang; Xiumei Wu; Jie Duan; David Hinrichs; Keith Wegmann; Gary L Zhang; Mark Hall; James T Rosenbaum
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.